{"id":"923a86cdb92f","type":"article","url":"https://hartvaat.nl/2018/10/02/cangrelor-bij-ticagrelor-geladen-stemi-patienten-tijdens-primaire-pci/","title":"Cangrelor bij ticagrelor-geladen STEMI-patiënten tijdens primaire PCI","title_en":"Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.","category":"algemeen","category_label":"Algemeen","professions":["apotheker","cardioloog"],"tags":[],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2018.07.041","source_url":"https://doi.org/10.1016/j.jacc.2018.07.041","authors":["Dimitrios Alexopoulos","Christos Pappas","Danai Sfantou","Ioanna Xanthopoulou","Matthaios Didagelos","Petros Kikas","Antonios Ziakas","Dimitris Tziakas","Haralambos Karvounis","Efstathios Iliodromitis"],"significance":5,"published":"2018-10-02","source_date":"2018-10-02","image":"","kennis":["https://hartvaat.nl/kennis/coronairlijden/stemi/"],"congress":"","summary_en":"This study investigated the pharmacodynamic interaction between cangrelor and ticagrelor preloading in STEMI patients undergoing primary PCI, addressing the practical question of sequential intravenous-to-oral antiplatelet transition.","created":"2026-07-03T10:27:32Z","updated":"2026-07-03T13:26:46Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Studie naar de interactie van cangrelor met ticagrelor-voorbehandeling bij STEMI-patiënten die primaire PCI ondergaan.","abstract_original":""}